BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2343917)

  • 1. Eye tracking impairment in clinically identified patients with schizotypal personality disorder.
    Siever LJ; Keefe R; Bernstein DP; Coccaro EF; Klar HM; Zemishlany Z; Peterson AE; Davidson M; Mahon T; Horvath T
    Am J Psychiatry; 1990 Jun; 147(6):740-5. PubMed ID: 2343917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye movements in spectrum personality disorders: comparison of community subjects and relatives of schizophrenic patients.
    Thaker GK; Cassady S; Adami H; Moran M; Ross DE
    Am J Psychiatry; 1996 Mar; 153(3):362-8. PubMed ID: 8610823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eye movement impairment and schizotypal psychopathology.
    Siever LJ; Friedman L; Moskowitz J; Mitropoulou V; Keefe R; Roitman SL; Merhige D; Trestman R; Silverman J; Mohs R
    Am J Psychiatry; 1994 Aug; 151(8):1209-15. PubMed ID: 8037257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired smooth pursuit eye movement: vulnerability marker for schizotypal personality disorder in a normal volunteer population.
    Siever LJ; Coursey RD; Alterman IS; Buchsbaum MS; Murphy DL
    Am J Psychiatry; 1984 Dec; 141(12):1560-6. PubMed ID: 6507660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attentional functioning in schizotypal personality disorder.
    Roitman SE; Cornblatt BA; Bergman A; Obuchowski M; Mitropoulou V; Keefe RS; Silverman JM; Siever LJ
    Am J Psychiatry; 1997 May; 154(5):655-60. PubMed ID: 9137121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF homovanillic acid in schizotypal personality disorder.
    Siever LJ; Amin F; Coccaro EF; Trestman R; Silverman J; Horvath TB; Mahon TR; Knott P; Altstiel L; Davidson M
    Am J Psychiatry; 1993 Jan; 150(1):149-51. PubMed ID: 8417559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial transmission of schizotypal and borderline personality disorders.
    Baron M; Gruen R; Asnis L; Lord S
    Am J Psychiatry; 1985 Aug; 142(8):927-34. PubMed ID: 4025588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological profile in patients with schizotypal personality disorder or schizophrenia.
    Matsui M; Sumiyoshi T; Kato K; Yoneyama E; Kurachi M
    Psychol Rep; 2004 Apr; 94(2):387-97. PubMed ID: 15154161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in reaction time between subjects with schizotypal and borderline personality disorders.
    Chapin K; Wightman L; Lycaki H; Josef N; Rosenbaum G
    Am J Psychiatry; 1987 Jul; 144(7):948-50. PubMed ID: 3605409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric disorders in the families of schizotypal subjects.
    Battaglia M; Gasperini M; Sciuto G; Scherillo P; Diaferia G; Bellodi L
    Schizophr Bull; 1991; 17(4):659-68. PubMed ID: 1805355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye tracking performance and the boundaries of the schizophrenia spectrum.
    Mitropoulou V; Friedman L; Zegarelli G; Wajnberg S; Meshberg J; Silverman JM; Siever LJ
    Psychiatry Res; 2011 Mar; 186(1):18-22. PubMed ID: 20826004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia.
    Keefe RS; Silverman JM; Mohs RC; Siever LJ; Harvey PD; Friedman L; Roitman SE; DuPre RL; Smith CJ; Schmeidler J; Davis KL
    Arch Gen Psychiatry; 1997 Feb; 54(2):169-76. PubMed ID: 9040285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A family study of schizophrenic and normal control probands: implications for the spectrum concept of schizophrenia.
    Baron M; Gruen R; Rainer JD; Kane J; Asnis L; Lord S
    Am J Psychiatry; 1985 Apr; 142(4):447-55. PubMed ID: 3976917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizotypal personality disorder in individuals with and without schizophrenic relatives: similarities and contrasts in neurocognitive and clinical functioning.
    Condray R; Steinhauer SR
    Schizophr Res; 1992 Apr; 7(1):33-41. PubMed ID: 1591195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Event-related potentials in schizotypal personality disorder.
    Trestman RL; Horvath T; Kalus O; Peterson AE; Coccaro E; Mitropoulou V; Apter S; Davidson M; Siever LJ
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):33-40. PubMed ID: 8845699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology of schizophrenia disorders: perspectives from the spectrum.
    Siever LJ; Davis KL
    Am J Psychiatry; 2004 Mar; 161(3):398-413. PubMed ID: 14992962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory P300 in borderline personality disorder and schizophrenia.
    Kutcher SP; Blackwood DH; St Clair D; Gaskell DF; Muir WJ
    Arch Gen Psychiatry; 1987 Jul; 44(7):645-50. PubMed ID: 3606330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A psychometric analysis of the social-interpersonal and cognitive-perceptual items for the schizotypal personality disorder.
    Widiger TA; Frances A; Trull TJ
    Arch Gen Psychiatry; 1987 Aug; 44(8):741-5. PubMed ID: 3632246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring smooth pursuit eye movement in psychiatric populations.
    Abel LA
    Am J Psychiatry; 1986 Jan; 143(1):111-2. PubMed ID: 3942258
    [No Abstract]   [Full Text] [Related]  

  • 20. Eye tracking, schizophrenic symptoms, and schizotypal personality disorder.
    Keefe RS; Siever LJ; Mohs RC; Peterson AE; Mahon TR; Bergman RL; Davis KL
    Eur Arch Psychiatry Neurol Sci; 1989; 239(1):39-42. PubMed ID: 2792157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.